Abstract View

Author(s): Rahil Salim Meman1*1, Furkhan Khan Younus Khan22

Email(s): 1memon.rahil99@gmail.com

Address:

    1 Department of Pharmaceutics, Ismail Mehta College of Pharmacy, Ambad. 2 Department of Pharmacology, Ismail Mehta College of Pharmacy, Ambad.

Published In:   Volume - 5,      Issue - 2,     Year - 2026

DOI: https://doi.org/10.71431/IJRPAS.2026.5202  

 View HTML        View PDF

Please allow Pop-Up for this website to view PDF file.

ABSTRACT:
The scarcity of compatible blood for transfusion remains a critical challenge in emergency medicine, particularly in trauma, surgical, and battlefield scenarios[1]. Plastic blood, or synthetic blood substitutes, represent a transformative advancement in addressing this global shortage. These engineered solutions utilize hemoglobin-based oxygen carriers (HBOCs) and perfluorocarbon products to provide immediate oxygen delivery without requiring blood typing or compatibility testing[2]. This research paper examines the current state of plastic blood technology, including its composition, mechanisms of action, clinical applications, advantages over traditional blood transfusions, and ongoing challenges in achieving widespread clinical implementation.

Cite this article:
Rahil Salim Meman, Furkhan Khan Younus Khan. Plastic Blood: Synthetic Blood Substitutes in Emergency Medicine for Patient Transfusion. IJRPAS, February 2026; 5(2): 11-19.DOI: https://doi.org/https://doi.org/10.71431/IJRPAS.2026.5202


1.    NHLBI. (2024). Potential game-changer for emergency medicine: Synthetic platelets. National Institutes of Health. https://www.nhlbi.nih.gov/news/2024/potential-game-changer-emergency-medicine-synthetic-platelets

2.    NIH/PMC. (2024). Artificial blood for therapeutic and laboratory usage. PubMed Central, 11427025. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC11427025/

3.    NIH/PMC. (1999). Blood substitutes: Haemoglobin therapeutics in clinical use. Transfusion Medicine Reviews, 13(4), 1-25. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC137240/

4.    NIH/PMC. (2020). Artificial blood: The history and current perspectives of hemoglobin-based oxygen carriers. Frontiers in Medicine, 7, 86. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC7086064/

5.    Science Magazine. (2024, July 2). The ultimate blood substitute? The U.S. military is betting $46 million. Science, 385(6), 245-248. https://www.science.org/content/article/ultimate-blood-substitute-us-military-betting-46-million

6.    NPR. (2025, July 24). Scientists are developing artificial blood that could save lives. Shots - Health News. https://www.npr.org/sections/shots-health-news/2025/07/24/nx-s1-5477632/artificial-blood-hemorrhage-emergency-medicine

7.    NIH/PMC. (2018). Artificial blood: A futuristic dimension of modern day transfusion medicine. Journal of Laboratory Medicine, 42(6), 234-245. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC6864588/

8.    ASH Clinical News. (2025, February 19). Banking on artificial blood. American Society of Hematology Clinical News. https://ashpublications.org/ashclinicalnews/news/8465/Banking-on-Artificial-Blood

9.    Al Jazeera. (2025, March 8). How close are scientists to producing artificial blood? Retrieved from https://www.aljazeera.com/news/2025/3/8/how-close-are-scientists-to-producing-artificial-blood

Related Images:



Recent Images



Pharmacological Properties of Amomum subulatum Roxb., a Significant Medicinal Herb
Clinical Trials of Traditional Herbal Medicines in India: Current Scenario and Challenges
Synthesis of Thiourea Derivatives as Bioisosteric Structures of SERMs Pursuant to Virtual Screening
A Narrative Review of the Prevalence, Types, and Contributing Factors of Drug-Related Problems in Hospitals.
A Review on Nature’s Neglected Treasures Unveiling Medicinal Use of Common Weeds in Drug Therapy: A Statistical Survey
Implantable Drug Delivery Systems: A Comprehensive Review with Recent Advancements
Beyond Diarrhea Control: Emerging Neuroimmune and Psychobiotic Roles of Bacillus clausii
Artificial Intelligence-Enabled Quality by Design and Regulatory Science for Apixaban Orodispersible Tablets: A Critical Review of Clinical Rationale, Formulation Strategy, and Submission-Ready Documentation for Stroke Prevention
Analysis of pro inflammatory cytokinse response among hepatitis B patients co-infected with Plasmodium falciparum in Khartoum state, Sudan
Dual Incretin Agonism in Type 2 Diabetes and Obesity: Systematic Review of Tirzepatide Mechanisms and Clinical Outcomes

Tags